{
  "pmcid": "4762183",
  "sha256": "40c1a7211263ee3b76df337b485e58330d138e6fb9e7f688a14c6ffc4593b751",
  "timestamp_utc": "2025-11-09T22:43:39.384650+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 12.102964734010762,
    "reading_ease": 28.561157601115752,
    "word_count": 239
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Impact of Patient Characteristics on Insulin Response During Non-Cardiac Surgery: A Randomised Controlled Trial"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Participants were randomised using a computer-generated sequence"
      },
      "Participants": {
        "score": 2,
        "evidence": "Eligibility criteria included adult patients scheduled for non-cardiac surgery"
      },
      "Intervention": {
        "score": 2,
        "evidence": "A total of 202 patients undergoing non-cardiac surgery were enrolled and received intraoperative intravenous insulin"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to evaluate these effects in non-cardiac surgical patients"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the change in blood glucose concentration 30 minutes after an initial insulin bolus"
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Participants were randomised using a computer-generated sequence, with allocation concealed via sealed envelopes"
      },
      "Blinding": {
        "score": 1,
        "evidence": "Blinding was applied to outcome assessors"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Of the 202 patients, 101 were randomised to each group"
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Analysis was performed on all participants using an intention-to-treat approach"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "Blood glucose concentrations decreased by 8.3 ±10 mg dl-1 (0.46 ± 0.56 mmol litre-1) per unit of insulin. The response was similar in patients with and without diabetes [adjusted mean difference (97.5% CI): 0.2 (-3.9, 4.2) mg dl-1, 0.01 (-0.22, 0.24) mmol litre-1, P = 0.93]"
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 19,
    "max_score": 25
  }
}